ÇİLLİ, A. Et Al. 2023. Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions. RESPIRATORY INVESTIGATION , vol.61 .

ÇİLLİ, A., ÜZER, F., COŞKUN, N. F., SEVİNÇ, C., URSAVAŞ, A., YILDIZ, P., ... PINAR DENİZ, P.(2023). Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions. RESPIRATORY INVESTIGATION , vol.61.

ÇİLLİ, AYKUT Et Al. "Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions," RESPIRATORY INVESTIGATION , vol.61, 2023

ÇİLLİ, AYKUT Et Al. "Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions." RESPIRATORY INVESTIGATION , vol.61, 2023

ÇİLLİ, A. Et Al. (2023) . "Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions." RESPIRATORY INVESTIGATION , vol.61.

@article{article, author={AYKUT ÇİLLİ Et Al. }, title={Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions}, journal={RESPIRATORY INVESTIGATION}, year=2023}